Is there a vaccine for Ebola ?

Is there a vaccine for Ebola ?

There are 2 licensed Ebola vaccines but not for the current strain that is happening in the Ituri province of DRC.

There are two licensed vaccines available for the prevention of Ebola virus disease caused by the Orthoebolavirus zairense species. 

• Ervebo (rVSV-ZEBOV): Manufactured by Merck, this is a single-dose, live-attenuated recombinant vesicular stomatitis virus vaccine.  It is approved by the FDA and WHO for individuals aged 12 months and older.  It is primarily recommended for ring vaccination during active outbreaks due to its rapid onset of protection. 
  Ervebo was licensed in November 2019 by the European Medicines Agency and prequalified by WHO. The United States Food and Drug Administration licensed the vaccine in December 2019 after which Burundi, Central African Republic, the Democratic Republic of the Congo, Ghana, Guinea, Rwanda, Uganda and Zambia also approved the vaccine.
• Zabdeno/Mvabea Developed by Johnson & Johnson, this is a two-dose regimen the doses are administered 56 days apart.  
• It is approved in the European Union and recommended for preventive vaccination in areas at lower risk or neighboring outbreak zones. 
• In May 2020, the European Medicines Agency recommended to grant marketing authorisation to a second new vaccine delivered in 2 doses called Zabdeno (Ad26.ZEBOV) and Mvabea (MVA-BN-Filo) for individuals 1 year and older.
• The vaccine is delivered in 2 doses: Zabdeno is administered first and Mvabea is given approximately 8 weeks later as a second dose. This prophylactic 2-dose regimen is therefore not suitable for an outbreak response where immediate protection is necessary.
• For individuals at imminent risk of exposure to Ebola who completed the Zabdeno and Mvabea 2-dose vaccination regimen, a Zabdeno booster vaccination should be considered if more than 4 months have passed since the second dose was administered.

Both vaccines are on the WHO List of Essential Medicines.